Switzerland · Hospital & health care startup
Switzerland · Qnomx
At Qnomx, we are transforming cancer genomic data interpretation to optimize therapy selection in oncology.
Funding reportedLast round: Seed
About Qnomx
At Qnomx, we are transforming cancer genomic data interpretation to optimize therapy selection in oncology.
Our QNOMX platform empowers labs to automate the final manual review of genomic profiles and streamline the genetic testing workflow, enhance efficiency, reduce costs, and increase productivity, ultimately accelerating the time from genomic testing to treatment decisions and improving the quality of those decisions.
What company datasets say Qnomx raised
Funding, as reported
Founders and team
From Qnomx's own website: 3 founders.
On 2 portfolio pages
Investors who name them
Each firm lists Qnomx on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
The company, in detail
What they build
Known for
health careclinical data interpretationgenomic data analysisai modelsscalable lab solutionslocal language reportinginformation technology & servicescancer genomics analysisgenomic report summarizationclinical report automationreport standardizationgenomic profile report interpretationscalable genomic analysishospital & health careai-driven test interpretationbioinformatics integration
Built with from their website
WordPress.orgApacheViewport MetaLucidePriority HintsMicrosoft ExchangeMicrosoft 365 Apps & ServicesMobile FriendlyOpen GraphRadix UI
+7 more
Microsoft Exchange OnlineNginxMicrosoft 365OutlookMicrosoft Email ProvidersIONOSGoogle Search Console
- Sector
- Hospital & health care
- Industry code
- NAICS 54171, 513210, SIC 8731, 7372
- Region
- Basel-Stadt
Hospital & health care in Switzerland
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Qnomx in front of investors. Or tell us what we have wrong.